PT  - JOURNAL ARTICLE
AU  - Hibberd, Matthew C.
AU  - Webber, Daniel M.
AU  - Rodionov, Dmitry A.
AU  - Henrissat, Suzanne
AU  - Chen, Robert Y.
AU  - Zhou, Cyrus
AU  - Lynn, Hannah M.
AU  - Wang, Yi
AU  - Chang, Hao-Wei
AU  - Lee, Evan M.
AU  - Lelwala-Guruge, Janaki
AU  - Kazanov, Marat D.
AU  - Arzamasov, Aleksandr A.
AU  - Leyn, Semen A.
AU  - Lombard, Vincent
AU  - Terrapon, Nicolas
AU  - Henrissat, Bernard
AU  - Castillo, Juan J.
AU  - Couture, Garret
AU  - Bacalzo, Nikita P.
AU  - Chen, Ye
AU  - Lebrilla, Carlito B.
AU  - Mostafa, Ishita
AU  - Das, Subhasish
AU  - Mahfuz, Mustafa
AU  - Barratt, Michael J.
AU  - Osterman, Andrei L.
AU  - Ahmed, Tahmeed
AU  - Gordon, Jeffrey I.
TI  - Bioactive glycans in a microbiome-directed food for malnourished children
AID  - 10.1101/2023.08.14.23293998
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.14.23293998
4099  - http://medrxiv.org/content/early/2023/08/16/2023.08.14.23293998.short
4100  - http://medrxiv.org/content/early/2023/08/16/2023.08.14.23293998.full
AB  - Evidence is accumulating that perturbed postnatal development of the gut microbiome contributes to childhood malnutrition1-4. Designing effective microbiome-directed therapeutic foods to repair these perturbations requires knowledge about how food components interact with the microbiome to alter its expressed functions. Here we use biospecimens from a randomized, controlled trial of a microbiome-directed complementary food prototype (MDCF-2) that produced superior rates of weight gain compared to a conventional ready-to-use supplementary food (RUSF) in 12-18-month-old Bangladeshi children with moderate acute malnutrition (MAM)4. We reconstructed 1000 bacterial genomes (metagenome-assembled genomes, MAGs) present in their fecal microbiomes, identified 75 whose abundances were positively associated with weight gain (change in weight-for-length Z score, WLZ), characterized gene expression changes in these MAGs as a function of treatment type and WLZ response, and used mass spectrometry to quantify carbohydrate structures in MDCF-2 and feces. The results reveal treatment-induced changes in expression of carbohydrate metabolic pathways in WLZ-associated MAGs. Comparing participants consuming MDCF-2 versus RUSF, and MDCF-2-treated children in the upper versus lower quartiles of WLZ responses revealed that two Prevotella copri MAGs positively associated with WLZ were principal contributors to MDCF-2-induced expression of metabolic pathways involved in utilization of its component glycans. Moreover, the predicted specificities of carbohydrate active enzymes expressed by polysaccharide utilization loci (PULs) in these two MAGs correlate with the (i) in vitro growth of Bangladeshi P. copri strains, possessing differing degrees of PUL and overall genomic content similarity to these MAGs, cultured in defined medium containing different purified glycans representative of those in MDCF-2, and (ii) levels of carbohydrate structures identified in feces from clinical trial participants. In the accompanying paper5, we use a gnotobiotic mouse model colonized with age- and WLZ-associated bacterial taxa cultured from this study population, and fed diets resembling those consumed by study participants, to directly test the relationship between P. copri, MDCF-2 glycan metabolism, host ponderal growth responses, and intestinal gene expression and metabolism. The ability to identify bioactive glycan structures in MDCFs that are metabolized by growth-associated bacterial taxa will help guide recommendations about use of this MDCF for children with acute malnutrition representing different geographic locales and ages, as well as enable development of bioequivalent, or more efficacious, formulations composed of culturally acceptable and affordable ingredients.Competing Interest StatementA.O. and D.R. are co-founders of Phenobiome Inc., a company pursuing development of computational tools for predictive phenotype profiling of microbial communities. C.B.L. is a co-founder of Infinant Health, interVenn Bio, and BCD Bioscience - companies involved in the characterization of glycans and developing carbohydrate applications for human health.Clinical TrialNCT04015999Clinical Protocols https://www.nejm.org/doi/suppl/10.1056/NEJMoa2023294/suppl_file/nejmoa2023294_protocol.pdf Funding StatementThe Bill & Melinda Gates Foundation, the National Institutes of Health (DK30292) and the Washington University-Centene Personalized Medicine Initiative. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The human study entitled Community-based Clinical Trial With Microbiota-Directed Complementary Foods (MDCFs) Made of Locally Available Food Ingredients for the Management of Children With Primary Moderate Acute Malnutrition (MAM), was approved by the Ethical Review Committee at the icddr,b (Protocol PR-18073; ClinicalTrials.gov identifier: NCT04015999). Informed consent was obtained for all participants. Specimens were shipped to Washington University, under a Materials Transfer Agreement, with approval from the Washington University Human Research Protection Office. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesShotgun DNA sequencing and microbial RNA-Seq datasets generated from fecal samples, plus annotated P. copri isolate genome sequences are available in the European Nucleotide Archive (accession PRJEB45356). LC-MS datasets of monosaccharide, glycoside linkage and polysaccharide data are deposited in GlycoPOST (accession GPST000244). https://www.ebi.ac.uk/ena/browser/view/PRJEB45356